Although it is known that long-acting GLP-1 receptor agonists have diminishing effects on gastric emptying over time, subcutaneous semaglutide is reported to continue to delay gastric emptying, implying that it is less affected by tachyphylaxis [22]
Current treatments aim to manage relapses, slow disease activity, and treat symptoms
Topical versions have a more limited, superficial effect
Furthermore, Chek1/2 inhibition was shown to reverse radioresistance in CD133-positive glioma stem cells [65]
In the context of MASLD/MASH, analogous rebound phenomena would be expected: regression of achieved steatosis resolution and potential re-emergence of inflammatory activity and fibrogenic stimuli upon drug withdrawal
Coders also need to be aware of billing requirements